Showing results (91-100 of 721) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|July 27, 2024
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 studyAlex F Herrera, Jasmine Zain, Kerry J Savage, et al.
The Lancet. Haematology|August 29, 2024
Management of pregnancies with anti-K alloantibodies and the predictive value of anti-K titration testingEvangelia Vlachodimitropoulou, Nadine Shehata, Greg Ryan, et al.
The Lancet. Haematology|May 25, 2024
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 studyJehan Dupuis, Emmanuel Bachy, Franck Morschhauser, et al.
The Lancet. Haematology|May 25, 2024
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMTSimona Pagliuca, Christoph Schmid, Nicole Santoro, et al.
The Lancet. Haematology|June 15, 2024
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational studyCarlos Bravo-Pérez, Ana Blanco, Nuria Revilla, et al.
The Lancet. Haematology|August 21, 2023
Measuring chronic myeloid leukaemia TKI-related toxic effects in the real world: a systematic review and critical assessment of content validity of patient-reported outcome measuresYolba Smit, Sanne J J P M Metsemakers, Jeroen J W M Janssen, et al.
The Lancet. Haematology|October 6, 2023
Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodiesRajshekhar Chakraborty, Paolo Milani, Giovanni Palladini, et al.
The Lancet. Haematology|September 30, 2023
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trialLuciano J Costa, Saurabh Chhabra, Eva Medvedova, et al.
The Lancet. Haematology|July 5, 2023
Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphomaJake S O'Donnell, Stewart K Hunt, Keith J Chappell
The Lancet. Haematology|July 6, 2023
Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trialLi Xuan, Yu Wang, Kaibo Yang, et al.
Pageof 73